Strides Pharma Science Limited — Rosuvastatin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Rosuvastatin · $21.0M export value · DGFT Verified
Strides Pharma Science Limited is the #1 Indian exporter of Rosuvastatin with $21.0M in export value and 420 verified shipments. Strides Pharma Science Limited holds a 4.5% market share in Rosuvastatin exports across 3 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Rosuvastatin Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Rosuvastatin?
Strides Pharma Science Limited exports Rosuvastatin to 3 countries. The largest destination is AUSTRALIA accounting for 98.6% of Strides Pharma Science Limited's Rosuvastatin shipments, followed by SOUTH AFRICA (1.2%) and FRANCE (0.2%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rosuvastatin from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APOTEX PTY LTD, | AUSTRALIA | $5.2M | 123 |
| ARROW PHARMACEUTICALS PTY LTD, | AUSTRALIA | $3.0M | 74 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $2.9M | 67 |
| APOTEX PTY LIMITED | AUSTRALIA | $2.0M | 45 |
| ARROW PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $1.3M | 30 |
| APOTEX PTY LTD | AUSTRALIA | $1.2M | 28 |
| ARROW PHARMACEUTICAL PTY LTD | AUSTRALIA | $1.1M | 24 |
| ARROW PHARMACEUTICAL PTY LIMITED | AUSTRALIA | $325.2K | 7 |
| TRINITY PHARMA PTY LIMITED | SOUTH AFRICA | $140.5K | 11 |
| ARROW PHARMACEUTICALS PTY LIMITED, | AUSTRALIA | $31.6K | 3 |
Strides Pharma Science Limited supplies Rosuvastatin to 15 buyers globally. The largest buyer is APOTEX PTY LTD, (AUSTRALIA), followed by ARROW PHARMACEUTICALS PTY LTD, (AUSTRALIA) and ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rosuvastatin Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $321.1M worth of Rosuvastatin through 13,477 shipments from 427 suppliers to 143 countries, serving 1,314 buyers globally. Strides Pharma Science Limited contributes $21.0M to this total, accounting for 4.5% of India's Rosuvastatin exports. Strides Pharma Science Limited ships Rosuvastatin to 3 countries through 15 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Rosuvastatin Exports?
Strides Pharma Science Limited's average Rosuvastatin shipment value is $50.0K per consignment, based on 420 shipments totaling $21.0M. The largest destination is AUSTRALIA (98.6% of Strides Pharma Science Limited's Rosuvastatin exports).
How Does Strides Pharma Science Limited Compare to Other Indian Rosuvastatin Exporters?
Strides Pharma Science Limited ranks #1 among 427 Indian Rosuvastatin exporters with a 4.5% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($58.9M), GLENMARK PHARMACEUTICALS LIMITED ($44.3M), BIOCON PHARMA LIMITED ($32.6M). Strides Pharma Science Limited processed 420 shipments to 3 destination countries.
What Rosuvastatin Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| APX-ROSUVASTATIN - ROSUVASTATIN TABLETS | $687.8K | 16 |
| APX-ROSUVASTATIN, ROSUVASTATIN TABLETS [ | $555.7K | 12 |
| APX-ROSUVASTATIN ROSUVASTATIN TABLETS 4 | $450.0K | 9 |
| CROSUVA 5 ROSUVASTATIN TABLETS (5MG) (FI | $386.1K | 9 |
| APX-ROSUVASTATIN ROSUVASTATIN TABLETS 1 | $322.4K | 7 |
| CROSUVA 40, ROSUVASTATIN TABLETS [40MG][ | $300.0K | 6 |
| CROSUVA 20 ROSUVASTATIN TABLETS 20MGF | $281.9K | 6 |
| APX-ROSUVASTATIN ROSUVASTATIN TABLETS [ | $270.5K | 6 |
| APX-ROSUVASTATIN ROSUVASTATIN TABLETS (1 | $242.7K | 5 |
| APX-ROSUVASTATIN ROSUVASTATIN TABLETS 2 | $231.8K | 5 |
Strides Pharma Science Limited exports 259 distinct Rosuvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APX-ROSUVASTATIN - ROSUVASTATIN TABLETS with 16 shipments worth $687.8K.
Regulatory Requirements: Exporting Rosuvastatin to Key Markets
What Strides Pharma Science Limited must comply with to export Rosuvastatin to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Rosuvastatin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $30.9M | 619 | 20 | $50.0K |
| 7 | TORRENT PHARMACEUTICALS LTD | $21.1M | 512 | 13 | $41.2K |
| 1 | STRIDES PHARMA SCIENCE LIMITED ★ | $21.0M | 420 | 3 | $50.0K |
| 8 | MEDREICH LIMITED | $16.7M | 684 | 13 | $24.5K |
| 10 | MYLAN LABORATORIES LIMITED | $13.0M | 621 | 9 | $21.0K |
Strides Pharma Science Limited ranks #1 among 427 Indian Rosuvastatin exporters. Average shipment value of $50.0K compared to the market average of $751.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Rosuvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,090 | 8.1% |
| SAHAR AIR | 921 | 6.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 909 | 6.7% |
| HYDERABAD ICD (INSNF6) | 878 | 6.5% |
| DELHI AIR CARGO ACC (INDEL4) | 769 | 5.7% |
| JNPT/ NHAVA SHEVA SEA | 699 | 5.2% |
| DELHI AIR | 635 | 4.7% |
| HYDERABAD ICD | 550 | 4.1% |
What Other Cardiovascular Products Does Strides Pharma Science Limited Export?
Strides Pharma Science Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Rosuvastatin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Rosuvastatin, top products include Ibuprofen, Gabapentin, Vancomycin, Prednisone, Mycophenolate. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rosuvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rosuvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 420 individual customs records matching Strides Pharma Science Limited exporting Rosuvastatin, covering 259 formulations to 3 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 143+ countries, 1,314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rosuvastatin Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Rosuvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Rosuvastatin Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rosuvastatin. For current shipment-level data, contact TransData Nexus.